CONCENTRATIONS |
9 Months Ended |
|---|---|
Jul. 31, 2025 | |
| Risks and Uncertainties [Abstract] | |
| CONCENTRATIONS |
NOTE 10 – CONCENTRATIONS
Significant Customers
During the three months ended July 31, 2025, the Company had two customers from whom it generated sales greater than 10% of net revenues. Revenue from these customers was $1,942,295, or 27.5% of net revenues during the three months ended July 31, 2025. Receivables from these customers were $723,585, or 18.7% of net receivables as of July 31, 2025.
During the three months ended July 31, 2024, the Company had one customer from whom it generated sales greater than 10% of net revenues. Revenue from this customer was $1,474,403, or 26.9% of net revenues during the three months ended July 31, 2024. Receivables from this customer were $18,784, or 0.6% of net receivables as of July 31, 2024.
During the nine months ended July 31, 2025, the Company had no customers from whom it generated sales greater than 10% of net revenues.
During the nine months ended July 31, 2024, the Company had one customer from whom it generated sales greater than 10% of net revenues. Revenue from this customer was $2,099,031, or 13.8% of net revenues during the nine months ended July 31, 2024. Receivables from this customer were $18,784, or 0.6% of net receivables as of July 31, 2024.
|
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|